Background: Radionuclides have important roles in clinical tumor radiotherapy as they are used to kill tumor cells or as imaging agents for drug tracing. The application of radionuclides has been developing as an increasing number of nanomaterials are used to deliver radionuclides to tumor areas to kill tumor cells. However, promoting the efficient combination of radionuclides and nanocarriers (NCs), enhancing radionuclide loading efficiency, and avoiding environmental pollution caused by radionuclide overuse are important challenges that hinder their further development.
Methods: In the present study, a new small molecule compound (3-[[(2S)-2-hydroxy-3-(4-hydroxyphenyl)-1-carbonyl] amino]-alanine, abbreviation: HN, molecular formula: CHNO) was synthesized as a linker between radionuclide iodine-125 (I) and NCs to enable a more efficient binding between NCs and radionuclides.
Results: In vitro evidence indicated that the linker was able to bind I with higher efficiency (labeling efficiency >80%) than that of tyrosine, as well as various NCs, such as cellulose nanofibers, metal oxide NCs, and graphene oxide. Single-photon emission computed tomography/computed tomography imaging demonstrated the biological distribution of I-labeled NCs in different organs/tissues after administration in mice.
Conclusion: These results showed an improvement in radionuclide labeling efficiency for nanocarriers and provided an approach for nanocarrier image tracing.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10898482 | PMC |
| http://dx.doi.org/10.2147/IJN.S446564 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development of a novel radioiodinated compound for amyloid and tau deposition imaging in Alzheimer's disease and tauopathy mouse models.
Neuroimage
December 2024
Department of Radiopharmacy and Molecular Imaging, Minhang Hospital & School of Pharmacy, Fudan University, Shanghai, China; Department of Functional Brain Imaging Research, China; Department of Clinical and Experimental Neuroimaging, Centre for Development of Advanced Medicine for Dementia, National Centre for Geriatrics and Gerontology, Obu, Japan; Key Laboratory of Smart Drug Delivery, Fudan University, Ministry of Education, Shanghai, China; Institute for Small-Molecule Drug Discovery & Development, Quzhou Fudan Institute, Quzhou, China. Electronic address:
Article Synopsis
- - The study focused on a new compound called AD-DRK (I-AD-DRK) that can non-invasively identify amyloid-β and tau deposits in the brain, which are critical for diagnosing Alzheimer's disease and related disorders.
- - Researchers conducted tests using this compound in both postmortem human brains and mouse models with amyloid and tau accumulation, demonstrating its effective binding and visualization capabilities in the brain regions associated with these proteins.
- - The results showed that I-AD-DRK has strong potential as a SPECT imaging agent, offering high-contrast imaging of amyloid and tau, which could significantly help in early diagnosis and treatment of Alzheimer's disease and other tauopathies.
Prediction of iodine-125 seed implantation efficacy in lung cancer using an enhanced CT-based nomogram model.
PLoS One
November 2024
The First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, China.
Background: Lung cancer, a leading cause of death, sees variable outcomes with iodine-125 seed implantation. Predictive tools are lacking, complicating clinical decisions. This study integrates radiomics and clinical features to develop a predictive model, advancing personalized treatment.
View Article and Find Full Text PDFInvestigation of a Radio-Iodinated Alpha-Mangostin for Targeting Estrogen Receptor Alpha (ERα) in Breast Cancer: In Silico Design, Synthesis, and Biological Evaluation.
Drug Des Devel Ther
October 2024
Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, 260-8675, Japan.
Article Synopsis
- Alpha-mangostin (AM), derived from the Purple Mangosteen, shows potential in breast cancer treatment and is believed to interact with the estrogen receptor alpha (ERα), but no direct binding studies had been conducted until this research.* -
- This study used iodine-125 labeled AM to explore its binding to ERα in lab-grown breast cancer cells (MCF-7) and demonstrated that AM and tamoxifen can inhibit its uptake, indicating that AM's uptake involves ERα.* -
- The injected labeled AM was found to accumulate in tumors in mice, but some of the iodine-125 was lost during the process, highlighting the need for further research to improve retention and effectiveness as a breast cancer treatment
A review of the efficacy and safety of iodine-125 seed implantation for lung cancer treatment.
Cancer Treat Res Commun
December 2024
Department of Respiratory and Critical Care Medicine, The First College of Clinical Medicine Science, China Three Gorges University, Yichang 443003, PR China; Department of Respiratory and Critical Care Medicine, 183 Yiling Road, Yichang Central People's Hospital, Yichang 443003, PR China; Clinical Medical Research Center for Precision Diagnosis and Treatment of Lung Cancer and Management of Advanced Cancer Pain of Hubei Province, Yichang 443003, PR China. Electronic address:
Article Synopsis
- * Radioactive iodine-125 (125-I) seed implantation therapy, known as brachytherapy, has shown promise by placing radioactive seeds directly into tumors, allowing targeted cancer cell destruction while protecting surrounding healthy tissue.
- * The review highlights the effectiveness and safety of 125-I brachytherapy alone or in combination with other treatments for lung cancer, but emphasizes the need for standardized dosing and protocols to improve treatment consistency and patient outcomes.
Pregnancy and survival-related outcomes of uveal melanoma treated with brachytherapy in women of reproductive age.
BMC Ophthalmol
September 2024
Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology & Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing Tongren Hospital, Beijing Tongren Eye Center, Capital Medical University, 1 Dong Jiao Min Lane,, Beijing, 100730, China.
Background: To examine if pregnancy affects the prognosis of uveal melanoma (UM) patients undergoing plaque brachytherapy (PBT) and to assess if PBT has any subsequent impact on pregnancy outcomes.
Methods: A retrospective, single-center study was carried out at Beijing Tongren Hospital, focusing on women of childbearing age diagnosed with UM and treated with iodine-125 plaque brachytherapy. Both the outcomes of pregnancies and the health status of the fetuses were monitored.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!